Disability risk or unimproved symptoms following shunt surgery in patients with idiopathic normal-pressure hydrocephalus: post hoc analysis of SINPHONI-2
Autor: | Shigeki Yamada, Teruo Kimura, Naoto Jingami, Masamichi Atsuchi, Osamu Hirai, Takahiko Tokuda, Masakazu Miyajima, Hiroaki Kazui, Etsuro Mori, Masatsune Ishikawa |
---|---|
Rok vydání: | 2016 |
Předmět: |
Male
medicine.medical_specialty Severity of Illness Index 03 medical and health sciences 0302 clinical medicine Risk Factors Modified Rankin Scale Post-hoc analysis medicine Humans In patient Aged Aged 80 and over Gait Disturbance business.industry General Medicine medicine.disease Shunt surgery Cerebrospinal Fluid Shunts Hydrocephalus Normal Pressure Surgery Hydrocephalus Shunt (medical) Treatment Outcome 030220 oncology & carcinogenesis Anesthesia Relative risk Disease Progression Quality of Life Female business 030217 neurology & neurosurgery |
Zdroj: | Journal of Neurosurgery. 126:2002-2009 |
ISSN: | 1933-0693 0022-3085 |
DOI: | 10.3171/2016.5.jns16377 |
Popis: | OBJECTIVEThe study aim was to assess the influence of presurgical clinical symptom severity and disease duration on outcomes of shunt surgery in patients with idiopathic normal-pressure hydrocephalus (iNPH). The authors also evaluated the cerebrospinal fluid tap test as a predictor of improvements following shunt surgery.METHODSEighty-three patients (45 men and 38 women, mean age 76.4 years) underwent lumboperitoneal shunt surgery, and outcomes were evaluated until 12 months following surgery. Risks for poor quality of life (Score 3 or 4 on the modified Rankin Scale [mRS]) and severe gait disturbance were evaluated at 3 and 12 months following shunt surgery, and the tap test was also conducted. Age-adjusted and multivariate relative risks were calculated using Cox proportional-hazards regression.RESULTSOf 83 patients with iNPH, 45 (54%) improved by 1 point on the mRS and 6 patients (7%) improved by ≥ 2 points at 3 months following surgery. At 12 months after surgery, 39 patients (47%) improved by 1 point on the mRS and 13 patients (16%) improved by ≥ 2 points. On the gait domain of the iNPH grading scale (iNPHGS), 36 patients (43%) improved by 1 point and 13 patients (16%) improved by ≥ 2 points at 3 months following surgery. Additionally, 32 patients (38%) improved by 1 point and 14 patients (17%) by ≥ 2 points at 12 months following surgery. In contrast, 3 patients (4%) and 2 patients (2%) had worse symptoms according to the mRS or the gait domain of the iNPHGS, respectively, at 3 months following surgery, and 5 patients (6%) and 3 patients (4%) had worse mRS scores and gait domain scores, respectively, at 12 months after surgery. Patients with severe preoperative mRS scores had a 4.7 times higher multivariate relative risk (RR) for severe mRS scores at 12 months following surgery. Moreover, patients with severe gait disturbance prior to shunt surgery had a 46.5 times greater multivariate RR for severe gait disturbance at the 12-month follow-up. Patients without improved gait following the tap test had multivariate RRs for unimproved gait disturbance of 7.54 and 11.2 at 3 and 12 months following surgery, respectively. Disease duration from onset to shunt surgery was not significantly associated with postoperative symptom severity or unimproved symptoms.CONCLUSIONSPatients with iNPH should receive treatment before their symptoms become severe in order to achieve an improved quality of life. However, the progression of symptoms varies between patients so specific timeframes are not meaningful. The authors also found that tap test scores accurately predicted shunt efficacy. Therefore, indications for shunt surgery should be carefully assessed in each patient with iNPH, considering the relative risks and benefits for that person, including healthy life expectancy. |
Databáze: | OpenAIRE |
Externí odkaz: |